Mounjaro ingredients: what is actually in the pen?

You've turned the pen over to read the label, here's what the ingredients list means

Most people flip the Mounjaro box over after their first injection and find a list of names that look more like a chemistry exam than a medicine label. That's a fair reaction. The active ingredient in Mounjaro is tirzepatide, printed first because it is the component doing the pharmacological work. Everything else on the label is an excipient, meaning its job is to keep tirzepatide stable, maintain the solution's acidity at a level tissue can tolerate, and prevent microbial contamination across the pen's four-week use window.

Tirzepatide itself is a 39-amino-acid peptide. It is synthesised in a laboratory (not extracted from animals or humans) and engineered to bind to both the GIP receptor and the GLP-1 receptor, the two gut-hormone pathways involved in appetite regulation and blood-sugar control. No other weight-management medicine currently licensed in the UK activates both receptors; that dual action is what sets the Mounjaro pen apart structurally from GLP-1-only treatments. The NHS's tirzepatide medicine page explains how the active ingredient works at a patient-friendly level, and the Mounjaro Summary of Product Characteristics (SmPC) on the eMC lists every ingredient with its precise function, both are worth bookmarking alongside any questions you bring to your prescriber.

The excipients in the UK formulation are: sodium phosphate dibasic heptahydrate and sodium phosphate monobasic monohydrate (the phosphate buffer pair that holds pH near 7.0), mannitol (a sugar alcohol used here as a tonicity agent rather than a sweetener), polysorbate 80 (a surfactant that stabilises the peptide), metacresol (the preservative that keeps each pen sterile across multiple injections), and water for injections. None of these are gluten, lactose or animal-derived.

What tirzepatide actually does once it's in your system

Tirzepatide does two things at once that single-pathway medicines can't replicate. By activating the GIP receptor it modulates fat storage and may improve how efficiently the body handles dietary fat. By activating the GLP-1 receptor it slows the rate at which food leaves the stomach, prompts the pancreas to release insulin in response to meals, and (crucially for weight management) signals fullness to the brain more persistently than the short-lived natural GIP and GLP-1 hormones do. The result, seen across the SURMOUNT clinical trial programme, is a sustained reduction in appetite and calorie intake that most people find hard to achieve through willpower alone.

If you want to go deeper on the mechanism, the page covering what Mounjaro actually does in the body walks through the pharmacology without jargon. For people already on Mounjaro who are thinking about what to eat alongside it, the guide on supplements to consider with Mounjaro covers protein, vitamins and micronutrients that can matter when appetite falls significantly. One practical note on storage: the pen lives in the fridge between 2°C and 8°C (many patients keep it in the fridge door) and the Patient Information Leaflet specifies the exact room-temperature window if you need to carry it out with you. Always refer to that leaflet rather than any third-party source for precise storage times.

Mounjaro is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. NICE's appraisal of tirzepatide (TA1026) sets out the criteria under which it is recommended, and those criteria inform what prescribers assess during consultation. A prescriber's view of the whole clinical picture (not BMI alone) determines suitability.

Ingredients questions that come up most often: allergens, interactions and what the pen does not contain

The most common ingredients-related questions our prescribers hear involve allergens and potential interactions with other medicines or supplements. On allergens: the UK Mounjaro formulation does not contain gluten, lactose, egg, soya, peanut, tree-nut or animal-derived proteins. Metacresol, the preservative, is worth flagging if you have a known sensitivity to cresol-based compounds, that is a conversation for your prescriber before you start. Polysorbate 80 is a well-established pharmaceutical excipient; allergy to it is rare but documented, so again, flag any prior reactions.

On interactions: tirzepatide slows gastric emptying, which affects the absorption rate of oral medicines taken at the same time. This is most clinically relevant for oral contraceptives, women taking the pill alongside tirzepatide are advised to use an additional barrier method for the first four weeks of treatment and for four weeks after each dose increase, because pill absorption may be reduced during that window. NHS England's guidance on weight-management injections covers this clearly. If you are on any long-term oral medication, bring a full list to your consultation.

Mounjaro does not contain insulin, human growth hormone, or any controlled substance. It is not derived from compounded sources; the medicine dispensed through a GPhC-registered UK pharmacy comes through the licensed UK supply chain from Eli Lilly. Concerns about counterfeit pens (a documented enforcement issue, with large seizures of fake products across 2024 and 2025) make that supply-chain point worth taking seriously. The Mounjaro cost and what's included guide explains what a legitimate private prescription involves, and how to verify any online pharmacy on the GPhC register before placing an order. For a fuller picture of what Mounjaro is and how it fits into weight management, the weight-loss treatment overview brings together the key context in one place.

If you'd like a prescriber to review whether Mounjaro is appropriate for you, check your eligibility with a free consultation, a GPhC-registered clinician, not an automated system, reads every submission the same day.